ターゲットシーケンスとリシーケンスの世界市場規模調査&予測、技術別(シーケンス、リシーケンス)、タイプ別(DNA、RNA)、用途別(臨床応用、植物・動物科学、医薬品開発、その他)、最終用途別(病院・診療所、学術研究、その他)と地域分析、2022-2029年Global Targeted Sequencing and Resequencing Market Size study & Forecast, by Technology (Sequencing, Resequencing) by Type (DNA, RNA), by Application (Clinical Application, Plant & animal sciences, Drug development, Others), by End-use (Hospitals & clinics, Academic Research, Others) and Regional Analysis, 2022-2029 世界のTargeted SequencingおよびResequencing市場は、2021年に約41億米ドルと評価され、予測期間2022-2029年に22.59%以上の健全な成長率で成長すると予測されています。Targeted Sequencingは、特定の遺伝子セッ... もっと見る
サマリー世界のTargeted SequencingおよびResequencing市場は、2021年に約41億米ドルと評価され、予測期間2022-2029年に22.59%以上の健全な成長率で成長すると予測されています。Targeted Sequencingは、特定の遺伝子セットにおける異常な変異を検出する方法であり、Resequencingは、遺伝子のサブセットを分離して配列決定する方法である。Targeted SequencingとResequencingは、ある人のゲノムの一部をシーケンスして、その人とその種の典型的なゲノムとの間の配列の不一致を探すために用いられる方法である。ショットガンとハイスループットが、DNAシーケンスの2大タイプです。ターゲットシーケンスやリシーケンスは、様々な先天性疾患に起因するDNAの変異を検出するために使用されます。WGSなどの調査方法と比較して、結果の適切な解析が可能であり、シーケンスデータの誤った解釈を防ぐことができます。フルゲノムシーケンスのコスト削減メリット、製薬業界における研究開発投資の増加、アンプリコンシーケンスと標的遺伝子パネルのメリット、シーケンス技術の技術的進歩が、主要な市場成長の要因となっています。国立医学図書館によると、フルゲノムシーケンスの費用は2007年で約1000万円。その後、シーケンスの価格は急速に低下し、1000ドルゲノムの実現も近いと予想されています。さらに、2019年、医薬品事業における研究開発費は830億ドルでした。特に、2015年から2019年にかけて、医薬品の研究開発への投資額は約50%急増しました。研究開発投資の増加は、革新的なSequencingおよびResequencing技術の開発につながります。フルゲノムシーケンスのコスト削減の利点と、製薬業界における研究開発投資の増加は、市場の成長を促進する主な要因です。その他、アンプリコンシーケンスや標的遺伝子パネルの利点、シーケンシング技術の技術的進歩も市場拡大を促進する要素です。さらに、デジタル次世代シーケンサー技術の出現と、より短時間でシーケンサーを実行するための進歩は、予測期間中に大きな市場機会を生み出す要因となっています。しかし、ターゲットシーケンスとリシーケンスを維持するための高いコストが、2022年から2029年の予測期間を通じて市場の成長を阻害します。 Targeted Sequencing And Resequencingの世界市場調査において考慮した主要地域は、アジア太平洋、北米、ヨーロッパ、ラテンアメリカ、およびその他の地域です。北米は、市場プレイヤーの優位性、技術の進歩の増加、同地域のシーケンス能力の開発の増加により、収益面で市場を支配しています。アジア太平洋地域は、研究開発への投資の増加、医薬品開発・発見のための先端技術の普及、主要プレイヤーの地域的拡大などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。 本レポートに含まれる主な市場プレイヤーは以下の通りです: イルミナ(Illumina, Inc. F.Hoffmann-La Roche Ltd. アジレント・テクノロジー株式会社(Agilent Technologies Inc. GATC Biotech Ag オックスフォード・ナノポア・テクノロジーズ サーモフィッシャーサイエンティフィック株式会社 DNASTAR Inc. QIAGEN BGI パーキンエルマー社(Perkin Elmer, Inc. 市場における最近の動向: 2021年1月、イルミナは、プレシジョンオンコロジーのための標準化された広く利用可能なツールを作成するという同社の目標をサポートする、メルク、ミリアドジェネティクス、クラオンコロジー、ブリストル・マイヤーズスクイブの複数の協業を発表しました。 2022年8月、The Medical Device Innovation Consortium(MDIC)は、公開ゲノムデータセットと治療関連サンプルの検証および開発により、NGSベースのがん診断を改善する取り組み、Somatic Reference Samples(SRS)を発表しました。 世界のTargeted Sequencing And Resequencing市場レポートスコープ: ヒストリカルデータ2019-2020-2021 推計基準年 2021年 予測期間 2022-2029 レポート対象 売上高予測、企業ランキング、競合状況、成長要因、トレンド 対象分野 技術, タイプ, アプリケーション, エンドユース, 地域 地域区分 北米、欧州、アジア太平洋、中南米、その他の地域 カスタマイズ範囲 レポート購入時に無料カスタマイズ(アナリストの作業時間8時間分まで)。国別、地域別、セグメント別スコープの追加・変更*。 本調査の目的は、近年における様々なセグメントおよび国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国において、業界の質的・量的な側面を取り入れるよう設計されています。 また、市場の将来的な成長を規定する推進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と技術提供の詳細な分析とともに、関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します: 技術別 シーケンサー リシーケンス タイプ別 DNA RNA 用途別に見る クリニカルアプリケーション 植物・動物科学 医薬品開発 その他 エンドユーズ別 病院・診療所 学術研究 その他 地域別 北アメリカ U.S. カナダ ヨーロッパ 連邦王国 ドイツ フランス スペイン イタリア ROE アジア太平洋 中国 インド 日本 オーストラリア 南朝鮮 ロアパック ラテンアメリカ ブラジル メキシコ その他の地域 目次Chapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion) 1.2.1. Targeted Sequencing And Resequencing Market, by Region, 2019-2029 (USD Billion) 1.2.2. Targeted Sequencing And Resequencing Market, by Technology, 2019-2029 (USD Billion) 1.2.3. Targeted Sequencing And Resequencing Market, by Type, 2019-2029 (USD Billion) 1.2.4. Targeted Sequencing And Resequencing Market, by Application, 2019-2029 (USD Billion) 1.2.5. Targeted Sequencing And Resequencing Market, by End-use, 2019-2029 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Targeted Sequencing and Resequencing Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Targeted Sequencing and Resequencing Market Dynamics 3.1. Targeted Sequencing and Resequencing Market Impact Analysis (2019-2029) 3.1.1. Market Drivers 3.1.1.1. Decreasing cost of full genome sequencing 3.1.1.2. increasing R&D investments in the pharmaceutical industry 3.1.2. Market Challenges 3.1.2.1. High Cost of maintaining Targeted Sequencing and Resequencing technology 3.1.3. Market Opportunities 3.1.3.1. Emerging digital next-generation sequencing technology 3.1.3.2. Advancements to perform sequencing in less time. Chapter 4. Global Targeted Sequencing and Resequencing Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029) 4.3. PEST Analysis 4.3.1. Political 4.3.2. Economical 4.3.3. Social 4.3.4. Technological 4.4. Investment Adoption Model 4.5. Analyst Recommendation & Conclusion 4.6. Top investment opportunity 4.7. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1. Assessment of the overall impact of COVID-19 on the industry 5.2. Pre COVID-19 and post COVID-19 Market scenario Chapter 6. Global Targeted Sequencing And Resequencing Market, by Technology 6.1. Market Snapshot 6.2. Global Targeted Sequencing And Resequencing Market by Technology, Performance - Potential Analysis 6.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Technology 2019-2029 (USD Billion) 6.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 6.4.1. Sequencing 6.4.2. Re-sequencing Chapter 7. Global Targeted Sequencing And Resequencing Market, by Type 7.1. Market Snapshot 7.2. Global Targeted Sequencing And Resequencing Market by Type, Performance - Potential Analysis 7.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Type 2019-2029 (USD Billion) 7.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 7.4.1. DNA 7.4.2. RNA Chapter 8. Global Targeted Sequencing And Resequencing Market, by Application 8.1. Market Snapshot 8.2. Global Targeted Sequencing And Resequencing Market by Application, Performance - Potential Analysis 8.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Application 2019-2029 (USD Billion) 8.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 8.4.1. Clinical Application 8.4.2. Plant & animal sciences 8.4.3. Drug development 8.4.4. Oyhers Chapter 9. Global Targeted Sequencing And Resequencing Market, by End-use 9.1. Market Snapshot 9.2. Global Targeted Sequencing And Resequencing Market by End-use, Performance - Potential Analysis 9.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by End-use 2019-2029 (USD Billion) 9.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 9.4.1. Hospitals & Clinics 9.4.2. Academic ResearchOthers Chapter 10. Global Targeted Sequencing And Resequencing Market, Regional Analysis 10.1. Targeted Sequencing And Resequencing Market, Regional Market Snapshot 10.2. North America Targeted Sequencing And Resequencing Market 10.2.1. U.S. Targeted Sequencing And Resequencing Market 10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029 10.2.1.2. Type breakdown estimates & forecasts, 2019-2029 10.2.1.3. Application breakdown estimates & forecasts, 2019-2029 10.2.1.4. End-use breakdown estimates & forecasts, 2019-2029 10.2.2. Canada Targeted Sequencing And Resequencing Market 10.3. Europe Targeted Sequencing And Resequencing Market Snapshot 10.3.1. U.K. Targeted Sequencing And Resequencing Market 10.3.2. Germany Targeted Sequencing And Resequencing Market 10.3.3. France Targeted Sequencing And Resequencing Market 10.3.4. Spain Targeted Sequencing And Resequencing Market 10.3.5. Italy Targeted Sequencing And Resequencing Market 10.3.6. Rest of Europe Targeted Sequencing And Resequencing Market 10.4. Asia-Pacific Targeted Sequencing And Resequencing Market Snapshot 10.4.1. China Targeted Sequencing And Resequencing Market 10.4.2. India Targeted Sequencing And Resequencing Market 10.4.3. Japan Targeted Sequencing And Resequencing Market 10.4.4. Australia Targeted Sequencing And Resequencing Market 10.4.5. South Korea Targeted Sequencing And Resequencing Market 10.4.6. Rest of Asia Pacific Targeted Sequencing And Resequencing Market 10.5. Latin America Targeted Sequencing And Resequencing Market Snapshot 10.5.1. Brazil Targeted Sequencing And Resequencing Market 10.5.2. Mexico Targeted Sequencing And Resequencing Market 10.6. Rest of The World Targeted Sequencing And Resequencing Market Chapter 11. Competitive Intelligence 11.1. Top Market Strategies 11.2. Company Profiles 11.2.1. Illumina, Inc. 11.2.1.1. Key Information 11.2.1.2. Overview 11.2.1.3. Financial (Subject to Data Availability) 11.2.1.4. Product Summary 11.2.1.5. Recent Developments 11.2.2. F. Hoffmann-La Roche Ltd 11.2.3. Agilent Technologies Inc. 11.2.4. GATC Biotech Ag 11.2.5. Oxford Nanopore Technologies 11.2.6. Thermo Fisher Scientific, Inc. 11.2.7. DNASTAR Inc. 11.2.8. QIAGEN 11.2.9. BGI 11.2.10. Perkin Elmer, Inc. Chapter 12. Research Process 12.1. Research Process 12.1.1. Data Mining 12.1.2. Analysis 12.1.3. Market Estimation 12.1.4. Validation 12.1.5. Publishing 12.2. Research Attributes 12.3. Research Assumption
SummaryGlobal Targeted Sequencing and Resequencing Market is valued at approximately USD 4.1 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 22.59% over the forecast period 2022-2029. Targeted Sequencing is a method of detecting unusual variants in a certain set of genes whereas, Resequencing is a method in which a subset of genes is isolated and sequenced. Targeted Sequencing and Resequencing are the methods used for the sequencing of a portion of a person's genome to look for sequence discrepancies between that person and the species' typical genome. Shotgun and high throughput are the two main types of DNA sequencing. Targeted sequencing and resequencing are used for the detection of mutations in DNA caused by various congenital diseases. In comparison to WGS and other survey methods, it provides a proper analysis of the results and prevents the erroneous interpretation of sequencing data. Cost-saving advantages of full genome sequencing, increasing R&D investments in the pharmaceutical industry, advantages of amplicon sequencing and targeted gene panels and Technological advancements in sequencing technology are the factors driving the major market growth. Table of ContentsChapter 1. Executive Summary1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion) 1.2.1. Targeted Sequencing And Resequencing Market, by Region, 2019-2029 (USD Billion) 1.2.2. Targeted Sequencing And Resequencing Market, by Technology, 2019-2029 (USD Billion) 1.2.3. Targeted Sequencing And Resequencing Market, by Type, 2019-2029 (USD Billion) 1.2.4. Targeted Sequencing And Resequencing Market, by Application, 2019-2029 (USD Billion) 1.2.5. Targeted Sequencing And Resequencing Market, by End-use, 2019-2029 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Targeted Sequencing and Resequencing Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Targeted Sequencing and Resequencing Market Dynamics 3.1. Targeted Sequencing and Resequencing Market Impact Analysis (2019-2029) 3.1.1. Market Drivers 3.1.1.1. Decreasing cost of full genome sequencing 3.1.1.2. increasing R&D investments in the pharmaceutical industry 3.1.2. Market Challenges 3.1.2.1. High Cost of maintaining Targeted Sequencing and Resequencing technology 3.1.3. Market Opportunities 3.1.3.1. Emerging digital next-generation sequencing technology 3.1.3.2. Advancements to perform sequencing in less time. Chapter 4. Global Targeted Sequencing and Resequencing Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029) 4.3. PEST Analysis 4.3.1. Political 4.3.2. Economical 4.3.3. Social 4.3.4. Technological 4.4. Investment Adoption Model 4.5. Analyst Recommendation & Conclusion 4.6. Top investment opportunity 4.7. Top winning strategies Chapter 5. Risk Assessment: COVID-19 Impact 5.1. Assessment of the overall impact of COVID-19 on the industry 5.2. Pre COVID-19 and post COVID-19 Market scenario Chapter 6. Global Targeted Sequencing And Resequencing Market, by Technology 6.1. Market Snapshot 6.2. Global Targeted Sequencing And Resequencing Market by Technology, Performance - Potential Analysis 6.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Technology 2019-2029 (USD Billion) 6.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 6.4.1. Sequencing 6.4.2. Re-sequencing Chapter 7. Global Targeted Sequencing And Resequencing Market, by Type 7.1. Market Snapshot 7.2. Global Targeted Sequencing And Resequencing Market by Type, Performance - Potential Analysis 7.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Type 2019-2029 (USD Billion) 7.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 7.4.1. DNA 7.4.2. RNA Chapter 8. Global Targeted Sequencing And Resequencing Market, by Application 8.1. Market Snapshot 8.2. Global Targeted Sequencing And Resequencing Market by Application, Performance - Potential Analysis 8.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by Application 2019-2029 (USD Billion) 8.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 8.4.1. Clinical Application 8.4.2. Plant & animal sciences 8.4.3. Drug development 8.4.4. Oyhers Chapter 9. Global Targeted Sequencing And Resequencing Market, by End-use 9.1. Market Snapshot 9.2. Global Targeted Sequencing And Resequencing Market by End-use, Performance - Potential Analysis 9.3. Global Targeted Sequencing And Resequencing Market Estimates & Forecasts by End-use 2019-2029 (USD Billion) 9.4. Targeted Sequencing And Resequencing Market, Sub Segment Analysis 9.4.1. Hospitals & Clinics 9.4.2. Academic ResearchOthers Chapter 10. Global Targeted Sequencing And Resequencing Market, Regional Analysis 10.1. Targeted Sequencing And Resequencing Market, Regional Market Snapshot 10.2. North America Targeted Sequencing And Resequencing Market 10.2.1. U.S. Targeted Sequencing And Resequencing Market 10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029 10.2.1.2. Type breakdown estimates & forecasts, 2019-2029 10.2.1.3. Application breakdown estimates & forecasts, 2019-2029 10.2.1.4. End-use breakdown estimates & forecasts, 2019-2029 10.2.2. Canada Targeted Sequencing And Resequencing Market 10.3. Europe Targeted Sequencing And Resequencing Market Snapshot 10.3.1. U.K. Targeted Sequencing And Resequencing Market 10.3.2. Germany Targeted Sequencing And Resequencing Market 10.3.3. France Targeted Sequencing And Resequencing Market 10.3.4. Spain Targeted Sequencing And Resequencing Market 10.3.5. Italy Targeted Sequencing And Resequencing Market 10.3.6. Rest of Europe Targeted Sequencing And Resequencing Market 10.4. Asia-Pacific Targeted Sequencing And Resequencing Market Snapshot 10.4.1. China Targeted Sequencing And Resequencing Market 10.4.2. India Targeted Sequencing And Resequencing Market 10.4.3. Japan Targeted Sequencing And Resequencing Market 10.4.4. Australia Targeted Sequencing And Resequencing Market 10.4.5. South Korea Targeted Sequencing And Resequencing Market 10.4.6. Rest of Asia Pacific Targeted Sequencing And Resequencing Market 10.5. Latin America Targeted Sequencing And Resequencing Market Snapshot 10.5.1. Brazil Targeted Sequencing And Resequencing Market 10.5.2. Mexico Targeted Sequencing And Resequencing Market 10.6. Rest of The World Targeted Sequencing And Resequencing Market Chapter 11. Competitive Intelligence 11.1. Top Market Strategies 11.2. Company Profiles 11.2.1. Illumina, Inc. 11.2.1.1. Key Information 11.2.1.2. Overview 11.2.1.3. Financial (Subject to Data Availability) 11.2.1.4. Product Summary 11.2.1.5. Recent Developments 11.2.2. F. Hoffmann-La Roche Ltd 11.2.3. Agilent Technologies Inc. 11.2.4. GATC Biotech Ag 11.2.5. Oxford Nanopore Technologies 11.2.6. Thermo Fisher Scientific, Inc. 11.2.7. DNASTAR Inc. 11.2.8. QIAGEN 11.2.9. BGI 11.2.10. Perkin Elmer, Inc. Chapter 12. Research Process 12.1. Research Process 12.1.1. Data Mining 12.1.2. Analysis 12.1.3. Market Estimation 12.1.4. Validation 12.1.5. Publishing 12.2. Research Attributes 12.3. Research Assumption
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
Bizwit Research & Consulting LLP 社の最新刊レポート
本レポートと同じKEY WORD(hospitals)の最新刊レポート
よくあるご質問Bizwit Research & Consulting LLP社はどのような調査会社ですか?Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/05 10:26 153.43 円 167.28 円 201.52 円 |